Alder Biopharmaceuticals Gets $40M Series C Financing

Alder Biopharmaceuticals, Inc., an antibody therapeutics startup, today announced the its Series C financing. Delphi Ventures and TPG Biotech led the $40 million round. Also participating in the round were existing investors Sevin Rosen Funds, Ventures West, H.I.G. Ventures, and WRF Capital. (read full story at: biospace.com)